Evidence map›Paper›PMID 35383871›Full record

ArticleHistology and histopathology2022

Histological diversity of anti-PD1-induced colitis.

Stratigoula Sakellariou, Evgenia Papathanasiou, Marina Perdiki, Maria Sotiropoulou, Evangelia Zampeli, Spyros Michopoulos, Giorgos Bamias, Ioanna Delladetsima

Abstract read
PubMed Publisher
In one paragraph

Article in Histology and histopathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Stratigoula SakellariouFirst Department of Pathology, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece. sakellarioustrat@yahoo.gr.
Evgenia PapathanasiouDepartment of Gastroenterology, Alexandra General Hospital, Athens, Greece.
Marina PerdikiLinköping University, Department of Pathology, Linköping, Sweden.
Maria SotiropoulouDepartment of Pathology, Alexandra General Hospital, Athens, Greece.
Evangelia ZampeliDepartment of Gastroenterology, Alexandra General Hospital, Athens, Greece.
Spyros MichopoulosDepartment of Gastroenterology, Alexandra General Hospital, Athens, Greece.
Giorgos BamiasGI Unit, 3rd Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria General Hospital, Athens, Greece.
Ioanna DelladetsimaFirst Department of Pathology, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
Alexandra Hospital · GRLaiko General Hospital of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimHistological data on anti-PD1-associated colitis are limited, while the colitis subtypes are still not clearly defined and different terms are being used. The aim of the study was to explore the histopathology of anti-PD1-induced colitis. METHODS AND

resultsColonic biopsies from 9 patients under anti-PD1 agents presenting diarrhea were examined. Histological evaluation revealed colitis of mild to moderate severity in almost all cases. Four distinct dominant histological patterns were identified with nearly the same incidence: Ulcerative colitis (UC)-like (n=2), GVHD-like (n=2), collagenous-like (n=3) and a mixed colitis pattern combining features of microscopic and UC-like colitis (n=2). The latter was additionally characterized by high crypt epithelium apoptosis and cryptitis with mixed inflammatory infiltrate. Thickening of the subepithelial band of collagen, detachment of the surface epithelium and increased apoptosis of the crypt epithelium were commonly encountered features, irrespective of colitis subtype. CD4/CD8 ratio was lower in the "combined" and higher in the GVHD-like subtype.

conclusionsAnti-PD1-induced colitis is expressed by different patterns of injury which share distinct histological hallmarks harboring diagnostic value, while a "combined" colitis subtype is being established. The histological alterations are indicative of mucosa barrier damage after antΙ-PD1 treatment and its participation in the pathogenetic process.

Indexed as

ColitisColitis, UlcerativeGraft vs Host DiseaseBiopsyCollagenHumansIntestinal MucosaCollagen

Identifiers

PMID35383871
OpenAlexW4225768551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.